A new study by the University of California, Davis, shows how cells work together to avoid a sudden drop in blood sugar. Understanding these feedback loops could improve the lives of people with ...

Nanologica AB ( ($SE:NICA) ) has issued an update. Nanologica AB has entered the Chinese insulin market with a SEK 2 million order for its ...

Dr Shivani Misra is a clinical associate professor and honorary consultant in diabetes at Imperial College London ...

CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...

Duke University scientists have discovered that pancreatic alpha cells, long believed to only produce glucagon, actually generate powerful amounts of GLP-1 — the same hormone mimicked by popular ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation - and pointing to a surprising new ally in the fight against type 2 diabetes.

In Medicare, insulin is covered under Medicare Part D, a Medicare Advantage prescription drug (MAPD) plan, or, in some cases, Medicare Part B. Since 2023, the Inflation Reduction Act (IRA) has capped ...

The risk of hypoglycemia and its serious medical sequelae restrict insulin replacement therapy for diabetes mellitus. Such adverse clinical impact has motivated development of diverse ...

1 School of Graduate Students, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China 2 The Second Department of Endocrine Diseases, First Affiliated Hospital, Heilongjiang ...

Insulin is rising in cost despite its necessity for survival for people with diabetes. Patent evergreening by insulin manufacturers hinders competition and keeps prices high. Congress should pass ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Lysophosphatidylinositol (LPI) bioactive ...